Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000614542 | SCV000715182 | likely benign | not specified | 2017-11-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000996375 | SCV001151061 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BS1, BS2 |
Labcorp Genetics |
RCV000996375 | SCV002468439 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279392 | SCV002565225 | likely benign | Ehlers-Danlos syndrome | 2021-09-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384314 | SCV002695789 | likely benign | Cardiovascular phenotype | 2019-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000996375 | SCV001808014 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000996375 | SCV001964850 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003953017 | SCV004774417 | likely benign | ZNF469-related disorder | 2020-02-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |